Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline
should not be considered exclusive of other methods of care reasonably directed at obtaining the
same results. e ultimate judgment concerning the propriety of any course of conduct must be
made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated
with the distributor of this clinical reference tool.
Abbreviations
AIT, amiodarone-induced thyrotoxicosis; ATD; Anti thyroid drugs; Bq, Becquerel;
BWPS; Burch-Wartofsky Point Scale; CAS; Clinical Activity Score; Ci, curie;
GD; Graves' disease; GO; Graves' orbitopathy; Gy, Gray; hCG; Human chorionic
gonadotropin; IgG; Immunoglobulin G; MMI, methimazole; PTU, propylthiouracil;
RAI, radioiodine; RAIU, radioactive iodine uptake; SH, subclinical hyperthyroidism;
Sv, Sievert; T
3
, triiodothyronine; T
4
, thyroxine; TA, toxic adenoma; THRB, thyroid
hormone receptor β; TMNG, toxic multinodular goiter; TRAb, thyrotropin receptor
antibodies; TSH, thyroid-stimulating hormone
Source
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees S, Samuels
M, Sosa JA, Stan MN, Walter M. 2016 American yroid Association Guidelines for
Diagnosis and Management of Hyperthyroidism and other causes of yrotoxicosis.
yroid. 2016 Oct;26(10):1343-1421.
American yroid Association, Inc.
6066 Leesburg Pike, Suite 550 • Falls Church, Virginia 22041
Phone: 703.998.8890 • Fax: 703.998.8893 • www.thyroid.org
Physician referral, patient resources available online in English and Spanish.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2016 All rights reserved
ATAHYPER16112f
